BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20260521T154631Z - 44298@eupv422
DTSTART;TZID=Europe/Berlin:20250519T080000
DTEND;TZID=Europe/Berlin:20250522T180000
CREATED:20260521T154631Z
DESCRIPTION:<a href="https://www.knauer.net/event/tides-usa-2025-30/registe
 r">Tides USA 2025</a>\nKNAUER will be exhibiting at TIDES USA 2025\, the l
 eading event for accelerating oligonucleotide and peptide therapeutics to 
 market. With over 500 attendees\, the conference will showcase the latest 
 advancements in oligonucleotide chemistry\, peptide development\, mRNA the
 rapeutics\, genome editing\, and drug delivery. Industry leaders will disc
 uss cutting-edge technologies and strategies aimed at improving R&D and CM
 C efficiency. It will offer a comprehensive view of current technologies\,
  market trends\, and innovative approaches\, including the development of 
 safe\, stable\, and effective drug delivery systems.
DTSTAMP:20260521T154631Z
LOCATION:Manchester Grand Hyatt San Diego\, 1 Market Place\, San Diego  921
 01\, United States
SUMMARY:Tides USA 2025
X-ALT-DESC;FMTTYPE=text/html:<a href="https://www.knauer.net/event/tides-us
 a-2025-30/register">Tides USA 2025</a>\nKNAUER will be exhibiting at TIDES
  USA 2025\, the leading event for accelerating oligonucleotide and peptide
  therapeutics to market. With over 500 attendees\, the conference will sho
 wcase the latest advancements in oligonucleotide chemistry\, peptide devel
 opment\, mRNA therapeutics\, genome editing\, and drug delivery. Industry 
 leaders will discuss cutting-edge technologies and strategies aimed at imp
 roving R&D and CMC efficiency. It will offer a comprehensive view of curre
 nt technologies\, market trends\, and innovative approaches\, including th
 e development of safe\, stable\, and effective drug delivery systems.
END:VEVENT
END:VCALENDAR